Prostanozol
Chemical compound
| Prostanozol | |
|---|---|
| INN | |
| Drug class | Androgen; Anabolic steroid; Androgen ether |
| Routes of administration | By mouth |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 1186001-41-1 |
| PubChem | 56842253 |
| DrugBank | |
| ChemSpider | 32700007 |
| KEGG | |
Prostanozol is a steroid that was first synthesized in the 1970s by Syntex, a multinational pharmaceutical company. It is a derivative of dihydrotestosterone (DHT), a naturally occurring hormone in the human body. Prostanozol is classified as an anabolic steroid, which means it promotes muscle growth.
History[edit]
Prostanozol was first synthesized in the 1970s by Syntex, a pharmaceutical company that was also responsible for the creation of other notable steroids such as Oxymetholone and Methandrostenolone. Despite its synthesis, Prostanozol was never marketed by Syntex and remained relatively unknown until the early 2000s.
Pharmacology[edit]
As a derivative of DHT, Prostanozol shares many of the same properties. It is an anabolic steroid, which means it promotes the growth of muscle tissue. However, unlike many other anabolic steroids, Prostanozol does not convert into estrogen in the body, which can lead to side effects such as water retention and gynecomastia.
Legal Status[edit]
In many countries, including the United States, Prostanozol is classified as a controlled substance. This means it is illegal to possess, use, or distribute without a prescription or license. In the world of professional sports, Prostanozol is banned by most major athletic organizations due to its performance-enhancing effects.
Side Effects[edit]
Like all anabolic steroids, Prostanozol can have serious side effects. These can include liver damage, cardiovascular issues, changes in mood and behavior, and in men, shrinkage of the testicles and development of breast tissue. Long-term use can also lead to dependency and withdrawal symptoms.
See Also[edit]
-
Prostanozol
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
